Technical Analysis for ATRS - Antares Pharma, Inc.

Grade Last Price % Change Price Change
grade C 3.4 -0.29% -0.01
ATRS closed down 0.29 percent on Wednesday, March 20, 2019, on 87 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical ATRS trend table...

Date Alert Name Type % Chg
Mar 20 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 20 Doji - Bullish? Reversal 0.00%
Mar 20 Down 3 Days in a Row Weakness 0.00%
Mar 20 Down 4 Days in a Row Weakness 0.00%
Mar 20 Down 5 Days in a Row Weakness 0.00%
Mar 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.29%
Mar 19 Down 3 Days in a Row Weakness -0.29%
Mar 19 Down 4 Days in a Row Weakness -0.29%
Mar 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.58%
Mar 18 Doji - Bullish? Reversal -2.58%

Older signals for ATRS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide. The company's products include Tjet/Zomajet, the needle-free auto injectors to deliver human growth hormone treatment to children without the use of a needle; twin-jector EZ II needle free injectors; Medi-Jet auto injectors; Elestrin, an estrogen replacement gel for the treatment of hot flashes; and Gelnique 3%, an oxybutynin gel product for the treatment of overactive bladder. The company is also developing OTREXUP, a product for the delivery of methotrexate using Medi-Jet technology for the treatment of rheumatoid arthritis, poly-articular-course juvenile rheumatoid arthritis, and psoriasis; and VIBEX QS T, an auto injector for the treatment of testosterone deficiency or replacement therapy. In addition, it is developing Vibex auto injectors; disposable pen injectors; and Nestragel, a contraceptive gel. Antares Pharma, Inc. has collaborative and license agreements with Ferring Pharmaceuticals BV; Teva Pharmaceutical Industries, Ltd.; JCR Pharmaceuticals Co., Ltd.; Actavis, Inc.; Daewoong Pharmaceuticals; BioSante Pharmaceuticals, Inc.; Meda Pharmaceuticals; Population Council; and Pfizer Inc. The company was founded in 1979 and is headquartered in Ewing, New Jersey.
Health Biotechnology Pharmaceutical Pharmacology Rheumatoid Arthritis Psoriasis Medical Equipment Overactive Bladder Testosterone Deficiency Teva Pharmaceutical Industries
Is ATRS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.96
52 Week Low 1.99
Average Volume 962,761
200-Day Moving Average 3.1645
50-Day Moving Average 3.2902
20-Day Moving Average 3.5785
10-Day Moving Average 3.537
Average True Range 0.1623
ADX 20.68
+DI 17.5927
-DI 28.3841
Chandelier Exit (Long, 3 ATRs ) 3.4731
Chandelier Exit (Short, 3 ATRs ) 3.6269
Upper Bollinger Band 3.9528
Lower Bollinger Band 3.2042
Percent B (%b) 0.26
BandWidth 20.91938
MACD Line 0.0532
MACD Signal Line 0.1013
MACD Histogram -0.0481
Fundamentals Value
Market Cap 531.78 Million
Num Shares 156 Million
EPS -0.12
Price-to-Earnings (P/E) Ratio -28.33
Price-to-Sales 5.48
Price-to-Book 7.21
PEG Ratio -0.24
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.61
Resistance 3 (R3) 3.61 3.54 3.58
Resistance 2 (R2) 3.54 3.49 3.54 3.56
Resistance 1 (R1) 3.47 3.45 3.44 3.47 3.55
Pivot Point 3.40 3.40 3.38 3.40 3.40
Support 1 (S1) 3.33 3.35 3.30 3.33 3.25
Support 2 (S2) 3.26 3.31 3.26 3.24
Support 3 (S3) 3.19 3.26 3.23
Support 4 (S4) 3.19